Tonix Pharmaceuticals’ TNX-102 SL Shows Promise as a Breakthrough Treatment for Fibromyalgia
The recent presentation by Tonix Pharmaceuticals Holding Corp. at the 2025 Annual European Congress of Rheumatology (EULAR) in Barcelona has brought hope to millions suffering from fibromyalgia. The company showcased...